industry project

Global In Vitro Diagnostics Market to be propelled by the Rising Prevalence of Infectious Diseases

Press Release   •   Oct 10, 2016 02:09 EDT

Market Research Reports Search Engine (MRRSE) has announced that its repository now features a report titled In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018” The report, by Transparency Research, states that the market for in vitro diagnostics is primarily driven by the growing popularity of automated and advanced diagnostics technologies, surging demand for rapid diagnostics and point-of-care testing, high prevalence of infectious diseases such as malaria, tuberculosis, and pneumonia, and a rapidly growing geriatric population. The high incidence of chronic diseases such as cardiovascular disorders, cancer, and diabetes can be attributed to the rapidly growing global geriatric population.

Medical devices in the form of apparatus, equipment, instrument, kits, or reagents that might either be used in combination with other similar devices or independently are known as in-vitro diagnostic products. These diagnostic tools provide crucial information pertaining to drug, therapy, health monitoring. This research report segments the global in vitro diagnostics market on the basis of type of product and geography. Based on product-type, the global in vitro diagnostics market is categorized into molecular diagnostics, blood testing, immunoassay, clinical chemistry, diabetes testing, and others, which include microbiological diagnostic techniques and flow cytometry.

Get a Free Sample Copy of the Report @

The qualitative and the quantitative information presented in this market study is based on primary and secondary sources of information. With the help of analytical tools such as the SWOT analysis and the Porter’s five forces analysis, this research report weighs out the opportunities and the glaring challenges in the global in vitro diagnostics market.

Across the in vitro diagnostics markets across China, India, and the U.S., the segment for clinical chemistry holds the highest share amidst the other product segments. However, it is the molecular diagnostics segment that is projected to grow substantially during the forecast period due to its capacity to diagnose diseases at the early stages. With growing demand for glucose testing strips and blood glucose meters owing to the high incidence of diabetes all over the world, the segment for diabetes testing is expected to grow robustly in the forthcoming years.

Geographically, this research report segments the global in vitro diagnostics market into Asia Pacific, North America, Europe, and Rest of the World. The report analyzes each regional market segment in terms of market size, demand drivers, supply side scenario, ongoing market trends, and expected market performance. This market study identifies the following companies in the global in vitro diagnostics market: Thermo Fisher Scientific Inc., Siemens Healthcare, Hoffman-La Roche Ltd., Life Technologies Corporation, Johnson & Johnson, Gen-Probe Incorporated, Beckman Coulter Inc., Bayer AG, and Becton, Dickinson and Company amongst other.

This report throws light on the competitive landscape by describing the profiles of the aforementioned companies. The report analyzes the companies on the basis of the following parameters: the key company facts, product portfolio, business strategies, financial overview, and the recent developments.